Interpreting thresholds for a clinically significant change in health status in asthma and COPD

被引:428
作者
Jones, PW [1 ]
机构
[1] St George Hosp, Sch Med, London SW17 0RE, England
关键词
airflow obstruction; asthma; chronic obstructive pulmonary disease; quality of life; respiratory rehabilitation;
D O I
10.1183/09031936.02.00063702
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Health status (or Health-Related Quality of Life) measurement is an established method for assessing the overall efficacy of treatments for asthma and chronic obstructive pulmonary disease (COPD). Such measurements can indicate the potential clinical significance of a treatment's effect. This paper is concerned with methods of estimating the threshold of clinical significance for three widely used health status questionnaires for asthma and COPD: the Asthma Quality of Life Questionnaire, Chronic Respiratory Questionnaire and St George's Respiratory Questionnaire. It discusses the methodology used to obtain such estimates and shows that the estimates appear to be fairly reliable, i.e. for a given questionnaire, similar estimates may be obtained in different studies. These empirically derived thresholds are all mean estimates with confidence intervals around them. The presence of these confidence intervals affects the way in which the thresholds may be used to draw inferences concerning the clinical relevance of clinical trial results. A new system of judging the magnitude of clinically significant results is proposed. Finally, an attempt is made to translate these thresholds into scenarios that illustrate what a clinically significant change with treatment may mean to an individual patient.
引用
收藏
页码:398 / 404
页数:7
相关论文
共 22 条
[1]
A comparison of global questions versus health status questionnaires as measures of the severity and impact of asthma [J].
Barley, EA ;
Jones, PW .
EUROPEAN RESPIRATORY JOURNAL, 1999, 14 (03) :591-596
[2]
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease [J].
Bestall, JC ;
Paul, EA ;
Garrod, R ;
Garnham, R ;
Jones, PW ;
Wedzicha, JA .
THORAX, 1999, 54 (07) :581-586
[3]
Griffiths TL, 2000, LANCET, V355, P1280
[4]
Interpreting treatment effects in randomised trials [J].
Guyatt, GH ;
Juniper, EF ;
Walter, SD ;
Griffith, LE ;
Goldstein, RS .
BRITISH MEDICAL JOURNAL, 1998, 316 (7132) :690-693
[5]
A MEASURE OF QUALITY-OF-LIFE FOR CLINICAL-TRIALS IN CHRONIC LUNG-DISEASE [J].
GUYATT, GH ;
BERMAN, LB ;
TOWNSEND, M ;
PUGSLEY, SO ;
CHAMBERS, LW .
THORAX, 1987, 42 (10) :773-778
[6]
MEASUREMENT OF HEALTH-STATUS - ASCERTAINING THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE [J].
JAESCHKE, R ;
SINGER, J ;
GUYATT, GH .
CONTROLLED CLINICAL TRIALS, 1989, 10 (04) :407-415
[7]
THE ST-GEORGE RESPIRATORY QUESTIONNAIRE [J].
JONES, PW ;
QUIRK, FH ;
BAVEYSTOCK, CM .
RESPIRATORY MEDICINE, 1991, 85 :25-31
[8]
A SELF-COMPLETE MEASURE OF HEALTH-STATUS FOR CHRONIC AIR-FLOW LIMITATION - THE ST-GEORGES RESPIRATORY QUESTIONNAIRE [J].
JONES, PW ;
QUIRK, FH ;
BAVEYSTOCK, CM ;
LITTLEJOHNS, P .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (06) :1321-1327
[9]
Quality of life changes in COPD patients treated with salmeterol [J].
Jones, PW ;
Bosh, TK .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (04) :1283-1289
[10]
QUALITY-OF-LIFE, SYMPTOMS AND PULMONARY-FUNCTION IN ASTHMA - LONG-TERM TREATMENT WITH NEDOCROMIL SODIUM EXAMINED IN A CONTROLLED MULTICENTER TRIAL [J].
JONES, PW .
EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (01) :55-62